Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats by unknown
RESEARCH Open Access
Localization of human adipose-derived
stem cells and their effect in repair of
diabetic foot ulcers in rats
Rongfeng Shi1†, Yinpeng Jin2†, Chuanwu Cao1,3, Shilong Han1,3, Xiaowen Shao4, Lingyu Meng2, Jie Cheng1,
Meiling Zhang1, Jiayi Zheng5, Jun Xu6,7* and Maoquan Li1,3*
Abstract
Background: Diabetic foot ulcer (DFU) is an intractable diabetic complication. Patients suffering from diabetes mellitus
(DM) frequently present with infected DFUs. In this study, a wound healing model on diabetic rat foot was established
to mimic the pathophysiology of clinical patients who suffer from DFUs. Our study aimed to explore the localization of
human adipose-derived stem cells (hADSCs) and the role of these cells in the repair of foot ulcerated tissue in diabetic
rats, and thus to estimate the possibilities of adipose-derived stem cells for diabetic wound therapy.
Method: Sprague–Dawley rats were used to establish diabetic models by streptozotocin injection. A full-thickness foot
dorsal skin wound was created by a 5 mm skin biopsy punch and a Westcott scissor. These rats were randomly divided
into two groups: the hADSC-treated group and the phosphate-buffered saline (PBS) control group. The hADSC or PBS
treatment was delivered through the left femoral vein of rats. We evaluated the localization of hADSCs with
fluorescence immunohistochemistry and the ulcer area and ulcerative histology were detected dynamically.
Result: The hADSCs had a positive effect on the full-thickness foot dorsal skin wound in diabetic rats with a
significantly reduced ulcer area at day 15. More granulation tissue formation, angiogenesis, cellular proliferation,
and higher levels of growth factors expression were also detected in wound beds.
Conclusions: Our data suggest that hADSC transplantation has the potential to promote foot wound healing in diabetic
rats, and transplantation of exogenous stem cells may be suitable for clinical application in the treatment of DFU.
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Background
Diabetes mellitus (DM) is a universal health problem. Ac-
cording to the World Health Organization, approximately
171 million people suffered from DM globally in 2000 and
this figure is projected to nearly double by 2030 [1]. It is
estimated that between 15 and 25 % of patients suffering
from DM develop foot ulcers during their lifetime, which
seriously affect their quality of life, can be life-threatening,
and are responsible for the majority of hospital admissions
among diabetics [2]. Diabetic foot ulcers (DFUs), which
pose substantial risks of seriously infection and amputa-
tion, constitute a major public health burden in both the
developed and developing world [3, 4]. The 5-year mortal-
ity rate associated with DFUs requiring amputation ranges
from 39 to 80 %, extremely close to the most aggressive
forms of cancer [5, 6]. Therefore, novel methods that
promote healing in diabetic foot disease are continuously
being investigated to reduce the morbidity and mortality.
Recent studies have reported that mesenchymal stem cell
(MSC) therapy may accelerate wound healing. Stem cells
represent a type of undifferentiated cells, which could be
expanded extensively in vitro [7]. Adult stem cells have
prolonged self-renewal potency with the ability to prolifer-
ate and differentiate into various cell types. Bone marrow-
derived mesenchymal stem cells (BMSCs) are an important
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source of adult stem cells which have been demonstrated
to contribute to the reconstitution of the dermal fibroblast
population and enhance wound healing [8]. Adipose-
derived stem cells (ADSCs) are another important source
of adult stem cells with characteristics similar to BMSCs,
including cell surface markers, gene expression profile,
immunosuppressive properties, and differentiation capacity
[9–11]. Moreover, ADSCs have several advantages includ-
ing ease of isolation, rapidity of expansion, and less donor
morbidity compared with BMSCs [12, 13]. ADSCs have
therefore been applied as an attractive cell source for cell
transplantation therapy in regenerative medicine, which
might be applied to the treatment of DFU [14, 15].
However, extensive preclinical studies are needed to
evaluate the treatment potential of ADSCs for DFU, and
the underlying mechanisms of cellular repair in DFUs
should be elucidated.
In the present study, we transplanted human ADSCs
(hADSCs) via the left femoral vein in the rat model of
diabetes, and examined their effects on wound healing
compared with vehicle control medium. The mobilization
and localization of transplanted hADSCs to DFUs were
detected using the lentivirus expressing ZsGreen. To
further explore the potential mechanisms of repairing
DFUs, we analyzed the inflammatory factors and the
growth factors in the foot ulcerative tissue. We found that
hADSCs localized superficially in ulcerative tissue,
reducing inflammation, promoting the release of growth
factors, and stimulating vasculogenesis and tissue repair in
DFUs. The obtained data provided important information
for the potential application of ADSC transplantation for
DFU treatment.
Methods
Animals and model for diabetic foot ulceration
Adult female Sprague–Dawley rats (150–200 g, grade:
clean, license: SCXK 2013-0005) at the age of 4–6 weeks
were purchased from SLAC Laboratory Animal Co., Ltd
(Shanghai, China) and used to establish a rat model for
diabetes. All rats were maintained on a 12-hour light
cycle in the animal facility of the Animal Unit of Tongji
University. All animal experiments were conducted in
accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals and
approved by the Biological Research Ethics Committee
of the Chinese Academy of Sciences. Diabetes was
induced in rats with streptozotocin injected intraperito-
neally once at a dose of 100 mg/kg (in 0.01 M sodium
citrate, pH 4.3). The blood glucose level was checked
daily and controlled between16.7 and 33.3 mmol/l by 6–
18 units/day of insulin (Wan-Bang Biochemical Medi-
cine Co. Ltd, Xuzhou, China). After 4 weeks, a model
for DFUs was created in rats as follows: anesthesia was
induced with isoflurane inhalation, and a single round
full-thickness skin wound was created on the dorsal hind
foot of the diabetic rats by a disposable 5 mm skin
biopsy punch and Westcott scissor.
Isolation and culture of hADSCs
hADSCs were isolated from the discarded part of the
transverse rectus abdominis musculocutaneous flap with
patient consent in accordance with procedures approved
by the Ethics Committee at the Chinese Academy of
Medical Sciences and Peking Union Medical College.
The fresh fat specimen was washed three times by
phosphate-buffered saline (PBS) with 1 % penicillin/
streptomycin and chopped by sterile operation scissors.
The chopped tissues were digested with 0.2 % collagenase
type I (Gibco, now part of Thermo Fisher Scientific,
Waltham, MA, USA) at 37 °C for 1.5 hours. The suspen-
sion was neutralized with isometric culture media and
centrifuged at 1500 rpm for 5 min. The cell pellet was
then resuspended in Dulbecco’s modified Eagle’s medium/
F12 (DMEM/F12) media (Gibco) supplemented with 10 %
fetal bovine serum (FBS) (Gibco). Cells were plated at a
density of 106 cells/ml and then maintained at 37 °C in a
humidified incubator supplemented with 5 % CO2, and
the media was changed every other day. For continuous
cell culture of hADSCs, the adherent hADSCs were
washed with PBS and transferred into a Petri dish contain-
ing culture medium with 0.2 % trypsin–EDTA at 37 °C for
2 min. The cell suspension was transferred into a 15 ml
tube and centrifuged at 1500 rpm for 5 min, the super-
natant was removed, the pallet of hADSCs was resus-
pended in the 15 ml tube of culture medium, and 6.0 ×
103/cm2 of hADSCs were plated onto Petri dishes for
continuous cell culture. The hADSCs at passage 4 were
used for the following experiments.
In-vitro adipogenic, chondrogenic, and osteogenic
differentiation of hADSCs
The culture-expanded hADSCs were tested for their
ability to differentiate into adipocytes, osteoblasts, and
chondrocytes. Passage 4 hADSCs at a density of 5 × 103
cells/cm2 were seeded into six-well plates precoated with
a cover glass and induced for 3 weeks with the adipogenic
(#HUXMA-90031; Cyagen Biosciences Inc., Guangzhou,
China), osteogenic (#HUXMA-90021; Cyagen Biosciences
Inc.), and chondrogenic (#HUXMA-90041; Cyagen Bio-
sciences Inc.) differentiation media, respectively. The cells
were then fixed in 10 % formalin and stained with
Oil Red O, Alizarin red, or Alcian blue in accordance
with the protocols of the manufacturer (Cyagen
Biosciences Inc.). Stained cells were washed three
times with PBS and detected using microscopy (IX71;
Olympus, Tokyo, Japan).
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Detection of hADSC surface markers using
immunofluorescent assay and flow cytometry
To observe the phenotypes, immunofluorescent assay and
flow cytometry were employed simultaneously. Passage 4
hADSCs were seeded into a six-well plate and cultured for
24 hours, fixed for 30 min using 4 % paraformaldehyde,
and incubated with CD29-FITC, CD44-PE, CD90-FITC,
CD105-PE, CD34-FITC, and CD133-PE anti-human anti-
bodies (0.5 μl/well) for 30 min. After three washes with
PBS, the fluorescence of hADSCs was observed. For flow
cytometry detection, passage 4 hADSCs were used to
prepare a single-cell suspension, and subsequently 2 μl of
CD29-FITC, CD44-PE, CD90-FITC, CD105-PE, CD34-
FITC, and CD133-PE antibodies were added to the
suspension. These cell aliquots were incubated for 30 min
on ice photophobically, washed three times, and then
detected using flow cytometry (BD FACSAria III; BD
Biosciences, San Jose, CA, USA).
Transfecting and tracing of transplanted hADSCs
Preparation of cell infection and lentiviral supernatants
was performed as described previously [16]. Briefly,
transient cotransfection of HEK293T cells were employed
to produce the lentiviral vectors with four plasmids
(Invitrogen). The vector-containing supernatants were
harvested 48 and 72 hours after transfection, filtered, and
then stored at −80 °C. hADSCs (passage 2) were infected
with the lentivirus expressing ZsGreen at 70 % cell conflu-
ence [17]. Three days after transfection, the infection
efficiency was detected using a fluorescence microscope
(IX71; Olympus), and the cells were cultured successively.
Twenty-four DFU model rats were injected with 5 × 106
ZsGreen-hASDCs via the femoral vein, and at 24 hours,
day 3 (D3), day 7 (D7), and day 15 (D15) the distribution
and engraftment of hADSCs in the wound bed were
detected dynamically using fluorescence immunohisto-
chemistry analysis with the antibodies specific against
ZsGreen (Abcam Ltd, Cambridge, UK).
Transplantation of hADSCs to diabetic rats
Thirty diabetic model rats with foot ulceration were suc-
cessfully duplicated and randomly divided into a hADSC-
treated group and a PBS control group. We bluntly
dissected the left femoral vein and injected 1 ml of
hADSC suspension (5 × 106 cells) via the femoral vein and
the control group was injected with 1 ml of PBS. Local
hemostasis and wound suturation were then performed.
At D3, D7, and D15 after transplantation of hADSCs, the
rats were sacrificed and the feet with diabetic ulcers were
harvested. The feet were cut off vertically along the center
line of the ulceration and divided into two equal parts.
Half of each foot was stored immediately in liquid nitro-
gen to survey the inflammatory factors and the growth
factors by proteome profiler array and enzyme-linked
immunosorbent assay (ELISA). The other half was fixed
in 4 % phosphate-buffered paraformaldehyde for histo-
logical assessment and immunohistochemical analysis.
Measurement of ulceration contraction rate
Before harvest, the size of the wounded area measured
with a ruler was recorded on parfocal digital photographs
taken of each rat’s foot at D3, D7, and D15 after injecting
the corresponding preparations (PBS for control group
and hADSCs for experimental groups). A digital camera
(DMC-LX5GK; Panasonic, Japan) was employed to take
pictures and the ulcer area was analyzed by Image-Pro
Plus 4.5 software [18].
Histological assessment of DFU healing
Half of the ulcerative tissue was collected from rat feet in
both groups, fixed in 4 % phosphate-buffered paraformal-
dehyde, embedded in paraffin, and sectioned at 4.0 μm.
The sections were dehydrated with successive concentra-
tions of ethanol and washed twice in distilled water. The
sections of the ulcerative tissue at D15 were stained with
hematoxylin and eosin (H&E) and with Masson’s
trichrome in accordance with the protocols of the ma-
nufacturer (Cyagen Biosciences Inc.) to detect the re-
epithelialization/granulation tissue formation and collagen
deposition, respectively. Analogously, the status of cell
apoptosis and proliferation in the diabetic ulcerative tissue
were detected using the terminal deoxynucleotidyl trans-
ferase dUTP nick end labeling (TUNEL) assay and Ki67
immunofluorescence staining (DAKO, CA, USA), respect-
ively. Finally, the histological sections were observed and
analyzed under a microscope (Leica DMR 3000; Leica
Microsystem) by two blinded experienced investigators.
Vessel density assessment
For microvessel density determination, the ulcerative
tissue was analyzed using immunostaining with mouse
anti-CD31 primary antibody. Briefly, after fixing, embed-
ding in paraffin, and dewaxing, the tissue sections were
blocked in 3 % normal goat serum/0.3 % Triton X-100/
0.1 % BSA (Sigma Aldrich) in PBS. The sections were then
incubated for 24 hours at 4 °C with the primary antibody
(primary) against CD31 (1:100 dilution, sc-53526; Santa
Cruz), followed by goat anti-mouse IgG (secondary) for
1 hour at room temperature. After hematoxylin staining,
tissue sections were washed and then dehydrated with
ethanol, treated with dimethylbenzene, and sealed for
microscopic analysis by two blinded experienced in-
vestigators. The number of CD31-positive vessels was
quantified using Image-Pro Plus 4.5 software across five
nonconsecutive tissue sections for each wound.
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Detection of growth factors and inflammatory factors
The growth factors and inflammatory factors were
detected by ELISA and proteome profiler array. The
other half of the tissue harvested from foot ulcers was
cut into smaller pieces and washed in sterile PBS. Total
protein was extracted, centrifuged, and resuspended in
sample application buffer containing a protease inhibitor
cocktail (Promega, Madison, WI, USA). The levels of
growth factors and inflammatory factors in the foot
ulcerative tissue were measured using the enzyme ELISA
kit (Shanghai ExCell Biology, Inc., Shanghai, China) and
proteome profiler array (R&D Systems, Inc., USA) in
accordance with the respective product instruction
manual. For growth factors, the optical density of each
well was determined by spectrophotometer under a
450 nm wavelength after a substrate solution of hydrogen
peroxide was added to the plate, and the concentrations
of cytokines were calculated. For inflammatory factors,
pixel densities on developed X-ray films were collected
and analyzed using Image-Pro Plus 6.0 image analysis soft-
ware (Media Cybernetics Inc, Silver Spring, MD, USA).
Statistical analysis
Data are expressed as mean ± SD of at least three inde-
pendent experiments. Differences between experimental
groups were assessed by Student’s t test or one-way ana-
lysis of variance (ANOVA) followed by Dunnett’s test.
For all statistical analyses, P < 0.05 was considered to be
statistically significant.
Results
Characterization of hADSCs for transplantation
After four passages in culture, the expanded hADSC popu-
lation became homogeneous, showing a monolayer of
adherent cells, demonstrating a typical fibroblast-like and
shuttle-shaped morphology. To characterize the phenotype
of hADSCs, immunofluorescent assay and flow cytometry
analysis were performed. The results revealed that CD44,
CD29, CD105, and CD90 were signally expressed, whereas
the cells expressed negligible levels of CD133, CD34, and
CD36 for immunofluorescent assay (Fig. 1a). Furthermore,
flow cytometry revealed more than 90 % of cells strongly
expressed surface antigens such as CD44 (90.3 %), CD90
(94.9 %), CD29 and CD105 (97.1 %) but were virtually
negative for CD133, CD34, and CD36 (all <3 %), which
were consistent with the outcome of the immuno-
fluorescent assay (Fig. 1b). To definitively characterize the
multipotency of hADSCs, a triplet differentiation assay was
performed, which included adipogenic differentiation,
osteogenic differentiation, and chondrogenic differentiation.
After culture in adipogenic induction media for 3 weeks,
more than 80 % of cells differentiated into adipocytes that
could be stained with Oil Red O. Similarly, after osteogenic
and chondrogenic induction, more than 70 % of cells
differentiated into osteoblasts and chondrocytes as demon-
strated by Alizarin red staining and Alcian blue staining, re-
spectively (Fig. 1c). The results of triplet differentiation
assay indicated that the multipotency of cultured hADSCs
was well maintained.
Macro-evaluation of ulceration healing
Thirty-six rats were successfully made into the model
for DFU, and were randomly assigned to two groups.
Half of the model rats (n = 18, treated group) were trans-
planted with hADSCs (5.0 × 106 cells/rat) and the other
half of the model rats (n = 18, control group) received
the same volume of PBS via the femoral vein. At D3, D7,
and D15 after treatment, the rats with DFUs were sacri-
ficed (six rats in each group at every time point). All rats
in both the treated group and the control group showed
no adverse reactions, with no significant body weight
changes during the 15-day experimental period. The
blood glucose level was checked every day, and there was
no significant difference between the two groups (26.9 ±
2.5 mmol/l in the control group vs 28.1 ± 3.1 mmol/l in
the treated group, P > 0.05). The representative ulceration
images for the two groups at D3, D7, and D15 post
treatment are presented in Fig. 2a. Figure 2b shows the
mean area of ulceration at relevant time points. At D3 post
treatment, incrustation was formed in both groups, and
the size of the foot ulcers were somewhat enlarged in the
both groups (29.2 ± 3.2 mm2 in the control group vs 27.9
± 2.9 mm2 in the treated group), which might be due to
the intense inflammatory reaction. At D7, the size of the
foot ulcers was significantly reduced in the group that
received hADSCs (23.9 ± 2.8 mm2 in the control group v.
18.9 ± 1.9 mm2 in the treated group, P < 0.01). At D15,
diabetic rat foot ulcers in the rats treated with hADSCs
were further reduced and tended to be nearly healed (16.6
± 2.1 mm2 in the control group vs 9.8 ± 1.1 mm2 in the
treated group, P < 0.05). Our data demonstrate that
transplanted hADSCs could improve foot ulcer healing in
diabetic model rats.
Histological assessment of wound healing
Histological analysis of the wound bed was performed to
further evaluate the healing of the foot ulcers. The histo-
logical observation demonstrated that the tissue regener-
ation was much greater in the group treated with hADSCs
compared with the PBS group. H&E-stained skin sections
from the wound bed at D15 after treatment showed that
wounds were not fully re-epithelialized in the control
group; however, nearly complete re-epithelialization was
achieved in the hADSC-treated group (Fig. 3a). Further-
more, the granulation tissue in the hADSC-treated group
was significantly thicker than that in the control group
(Fig. 3b, c: 332.8 ± 31.8 μm vs 226.6 ± 27.5 μm, P < 0.05).
Collagen formation in the callus at D15 after treatment was
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assessed by Masson trichrome staining using computer-
assisted morphometric analysis. Figure 4c, e show the pres-
ence of a large amount of collagen deposition organized in
aligned fibers in the hADSC-treated rats, but relatively less
in the PBS-treated rats. The mean density values of the
hADSC-treated group was 0.615 ± 0.047, and for the con-
trol group was 0.295 ± 0.026 (P < 0.05). These findings indi-
cate that hADSCs significantly accelerated epithelialization,
formation of granulation tissue, and collagen deposition,
and thus promoted wound healing of the DFUs in rats.
Fig. 1 Characterization of hADSCs. a Immunofluorescent assay indicated that ADSCs were positive for cell surface markers CD44, CD29, CD105, and
CD90 and were negative for CD133, CD34, and CD36. Scale bar, 50 μm. b Flow cytometry also revealed that CD29, CD44, CD90, and CD105 were
highly expressed and CD133, CD34, and CD36 were negligible for the cells. c Triplet differentiation assays revealed that ADSCs could differentiate into
adipocytes (a), osteocytes (b), and chondrocytes (c), which were stained by Oil Red O, Alizarin red, and Alcian blue, respectively. Scale bar, 25 μm
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Effects of hADSC treatment on angiogenesis, cell
proliferation, and apoptosis
Because angiogenesis is a critical factor for skin wound
healing, the vascularity of wound granulation tissue was
evaluated. The small blood vessels of the wounds were
characterized by CD31 immunohistochemical staining of
4 μm tissue sections at D15 to detect neovascularization.
We found that large and dense vessels were growing widely
in wound granulation tissue of the hADSC-treated group.
However, only puny and narrow new vessels at the wound
bed were presented in the control group. There was a
significant increase in the density of CD31-positive capillary
lumens in the hADSC-treated wounds and the hADSC
transplantation significantly enhanced the wound angiogen-
esis (Fig. 4a, b). Given that the cellular proliferation in the
wound tissues may contribute to the ulcer healing, we next
investigated whether the hADSC transplantation promoted
cellular proliferation by Ki-67 staining. The Ki67-positive
cells were distributed diffusely in the basal layer of the
epidermis of the hADSC-treated group but less in the
control group. The mean density of Ki67 expression in the
hADSC-treated groups at D15 was significantly higher
compared with the control group (Fig. 4c, d). TUNEL
assays were used to detect whether hADSC treatment
reduced the apoptosis. The tissue sections of the control
group were distinctly characterized by apoptotic nuclei
cells, indicative of cellular apoptosis, whereas fewer apop-
totic cells were observed in the hADSC-treated group, and
quantification analysis revealed that approximately 40 % of
apoptotic cells were reduced in the hADSC-treated group
compared with the control group (Fig. 4e, f). These results
demonstrated that hADSC transplantation promoted cellu-
lar proliferation and reduced apoptosis simultaneously in
the process of ulcer healing.
Fate of hADSCs after transplantation
To trace the distribution of transplanted hADSCs in foot
ulcer tissues of the diabetic rats, we employed the lenti-
virus expressing ZsGreen to infect the hADSCs and
injected it via the femoral vein. The labeling efficiency of
the hADSCs was more than 80 %, and their corresponding
progenies were traced using a fluorescence microscope at
488 nm (Fig. 5a). The frozen sections of ulcer tissues were
made at 24 hours, D3, D7, and D15 after transplantation,
and the intensity and distribution of green fluorescence
were detected immediately. The number of ZsGreen-
positive cells in these fields was counted by two observers
blinded to the observational group and total cell numbers
Fig. 2 Diabetic foot ulceration healing at different time points after treatment in the hADSC-treated and control groups. a Representative images
of ulcerations on diabetic rat feet at D3, D7, and D15 after treatment with hADSCs and PBS. b Mean area of diabetic foot ulceration in
hADSC-treated model rats during observation compared with control model rats at D3, D7, and D15 after treatment. Averaged data
presented as mean ± SD. *P < 0.05, **P < 0.01. d days, hADSC human adipose-derived stem cell, PBS phosphate-buffered saline.
Representative images and mean area of the foot ulcers in the euglycemic rats group were shown in additional file 1
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in these fields were also counted. The ZsGreen-positive
cells were observed in the ulcer tissues 24 hours after
hADSC transplantation, suggesting that transplanted cells
could rapidly reach the injury skin tissues. Moreover, we
also found ZsGreen-positive cells in the ulcer tissues at
D3, D7, and D15 after transplantation (Fig. 5b). The rate
of ZsGreen-positive cells was gradually increased during
the first week after transplantation, and the highest inten-
sity was observed at D7 with a rate of 15.1 %. As time
went on, the intensity was slightly decreased at D15.
Nonetheless, a considerable quantity of ZsGreen-positive
cells (13.6 %) survived in the ulcer tissues (Fig. 5c). Our
data demonstrated that the hADSCs transplanted via the
femoral vein had the ability to migrate to the wound area
to participate in the whole wound healing process.
Variation of growth factors and inflammatory factors after
hADSC treatment
To explore the potential correlation between particular
growth factor levels and the wound healing process after
hADSC treatment, the levels of VEGF, bFGF, and TGF-β
were measured by ELISA. The growth factor levels in
wound beds were obviously higher in the hADSC-treated
group compared with the control group at D7 and D15
after treatment, especially VEGF and bFGF. However, at
D3 these growth factors level did not show any difference
between the two groups (Fig. 6a). The data were consist-
ent with the process of area decrease in foot ulcers and
the quantity of hADSCs migrated to the wound beds.
Various cytokines and chemokines play critical roles in
inflammation, and multiple factors compose a network in
which one cytokine is regulated by one or more other
cytokines. A proteome profiler array was employed to
detect the cytokines and chemokines in the ulcer tissues
at D3, which allowed simultaneously analysis of 28 factors
in a single experiment to investigate the multi-target
strategy. After transplantation with hADSCs, multiple
cytokines such as, IL-1ra, IL-2, TNF-α, and CNTF
were significantly restrained, and the expressions of
IL-1β, IL-6, IL-13, CCL3, CINC-1, CINC-2α/β, CINC-
3, CX3CL1, LECAM-1, and LIX were significantly
upregulated (P < 0.05 or P < 0.01), indicating that
transplanted hADSCs could modulate the synthesis of
several cytokines which were involved in the in-
flammatory process to inhibit inflammatory reaction
(Fig. 6b).
Fig. 3 Effects of hADSCs on the epithelialization and granulation tissue regeneration at D15 after treatment. a H&E staining of sections showed better
dermal re-epithelialization on the foot ulcers in model rats treated with hADSCs compared with control model rats. Scale bar, 100 μm. b Granulation
tissues in the hADSC-treated group were thicker than those in the PBS-treated group. Scale bar, 100 μm. c Statistical thickness of granulation tissues
by computer-assisted morphometric analysis. d Collagen deposition assessed by Masson Trichrome staining. The hADSC-treated group showed more
intense blue staining than the PBS-treated group, suggesting that hADSC treatment accelerated collagen deposition in the granulation tissues. Scale
bar, 50 μm. e Quantification analysis of the Masson Trichrome staining section by digital image analysis. Averaged data presented as mean ± SD.
*P < 0.05. hADSC human adipose-derived stem cell, PBS phosphate-buffered saline
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Discussion
Successful wound healing is a dynamic and complex
process including a series of coordinated events: in-
flammation, cell migration, proliferation, differentiation,
angiogenesis, fibroplasia, re-epithelialization, and tissue
remodeling [19]. Many factors can impair wound healing
in chronic wounds such as DFU, including infection,
necrosis, tissue hypoxia, and excess levels of inflammatory
cytokines, which prolong one or more phases of inflam-
mation, proliferation, and remodeling [20]. Chronic lower
extremity wounds have become some of the most
common and severe complications of diabetes, and as the
number of people diagnosed with diabetes continues to
increase, so will the number of DFUs. During the past
decades, many doctors and scientists have employed
different approaches to promote ulcer healing, such as
hyperbaric oxygen therapy [21], electrical stimulation [22],
negative pressure wound therapy [23], and bioengineered
skin [24]. However, there is not yet an ideal therapy that is
widely acceptable. The ideal modality of wound healing in
DFUs should have the synergistic effects of reducing
inflammation, forming vital granulation tissue, and accel-
erating cellular proliferation and angiogenesis.
Stem cells are characterized by their ability to sustain
self-renewal and multilineage differentiation and to form
terminally differentiated cells under particular conditions
[25]. These characteristics make stem cells ideal materials
for renovation in tissue damage. Abundance in source,
minimal invasion to acquire, efficacy, and safety for use
are the ideal criteria of stem cell types for clinical use [26].
Wu et al. [27] have reported that the healing of wounds
could be promoted through delivery of BMSCs, providing
strong evidence that MSCs have the extraordinary plasti-
city and the ability to secrete growth factors which could
accelerate wound healing. BMSCs are considered a bench-
mark for clinic purposes; however, BMSC isolation
involves an invasive and painful procedure with the low
yield [28, 29]. On the contrary, similar to BMSCs, ADSCs
are also pluripotent cells that possess stem cell cha-
racteristics, such as extensive proliferation capacity, and
Fig. 4 Effects of hADSCs on angiogenesis, cell proliferation, and apoptosis of wounds at D15 after treatment. a Immunohistochemical staining of
CD31 showed more blood vessel structures on the wound bed in model rats treated with hADSCs were clearly increased compared with control
model rats. Scale bar, 50 μm. b Quantification of blood vessel density expressed as the average number of CD31+ vessels per high-power field.
c Cellular proliferation on the wound bed observed by Ki-67 immunofluorescence staining. The hADSC-treated group showed more positive cells than
the PBS-treated group, indicating that hADSC treatment promoted cell proliferation in DFU healing. Scale bar, 100 μm. d Quantification analysis of the
Ki-67 staining by digital image analysis. e Apoptotic cells detected by TUNEL assays. Few apoptotic cells were detected in the hADSC-treated group,
suggesting that hADSC treatment reduced the apoptosis in the process of healing. Scale bar, 100 μm. f Quantification of TUNEL immunofluorescence
staining by digital image analysis. Averaged data presented as mean ± SD. *P < 0.05, **P < 0.01. hADSC human adipose-derived stem cell, PBS
phosphate-buffered saline, TUNEL terminal deoxynucleotidyl transferase dUTP nick end labeling
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differentiation potential to chondrocytes, adipocytes,
neuron-like cells, and liver-like cells [30–32]. They
present low immunogenicity and appear to be more
genetically stable in long-term culture compared with
BMSCs [33, 34]. Furthermore, ADSCs have several
outstanding features and advantages described previ-
ously [12, 13]. Recent studies have shown that ADSC
transplantation displays good therapeutic efficacy for
various diseases, including diabetic skin ulcer [35].
Different to the ordinary diabetic ulcer, the pathogen-
esis of ulcer formation on the diabetic foot is more
complex, usually accompanied with the pathological
changes of peripheral vessel and nerve, and severe
infection. In this respect, our data have demonstrated
that hADSC transplantation could also efficiently
accelerate the ulcer healing on the foot of diabetic rats.
Because of the low immunogenicity, although we used
hADSCs to transplant into immunocompetent rats
instead of immunodeficient recipients, no obvious
immunologic rejection reaction was found throughout
the process. Many other researchers have also reported
that they successfully transplanted human MSCs and
human neural stem cells into immunocompetent ro-
dent hosts and acquired functional outcomes [36, 37].
The potential of ADSCs that may benefit chronic wound
healing include their ability to migrate to the site of in-
flammation and injury, participate in regeneration of dam-
aged tissues, stimulate proliferation and differentiation of
resident progenitor cells, promote angiogenesis and recov-
ery of injured cells through growth factor secretion, facili-
tate matrix remodeling in the re-epithelialization phase,
and exert immunomodulatory and anti-inflammation
effects [38]. In this study, we successfully duplicated the
diabetic rat of foot ulceration model and transplantation
with the hADSCs. The results demonstrated that these
cells specifically targeted the foot ulcerative tissue within a
short period of time after treatment with hADSCs, which
was infected with the lentivirus expressing ZsGreen
(Fig. 5). The localization of the cells associated with the
hADSC transplantation was significant, and progressive
restoration of normal tissue structure in the DFUs, with a
dramatic reduction in the measured size of ulceration in
hADSC-treated rats compared with the control rats,
demonstrated a positive effect towards enhancing wound
healing in diabetic rats. The main findings of this study
are as follows: transplanted hADSCs particularly mi-
grated to or found home in the wound tissues and con-
tributed to tissue cells; transplanted hADSCs promoted
Fig. 5 Fate of hADSCs after transplantation in DFUs. a hADSCs were labeled by the lentivirus expressing ZsGreen and detected under bright-field and
green fluorescence. Scale bar, 25 μm. b Images of transplanted ZsGreen-positive cells at different time points in DFUs. The rate of ZsGreen-positive cells
was gradually increased during the first week after transplantation, with the highest intensity on D7. Scale bar, 100 μm. c Rate of ZsGreen-positive cells
at different time points. d days, h hours, hADSC human adipose-derived stem cell
Shi et al. Stem Cell Research & Therapy  (2016) 7:155 Page 9 of 13
re-epithelialization and granulation tissue formation;
transplanted hADSCs significantly enhanced angiogen-
esis and cellular proliferation, and decreased cellular
apoptosis; and transplanted hADSCs increased growth
factor (VEGF, bFGF, and TGF-β) secretion and
restrained the inflammation reaction. There is compel-
ling evidence that ADSCs would be a powerful tool in
regenerative medicine, suggesting the potential utility
for the clinical management. The data collected from
our study are consistent with the therapeutic effects of
hADSCs reported previously on osteogenic defect [39]
and Crohn’s disease [40]. In the current study, we not
only validated the specific localization of hADSCs in
diabetic foot ulcerative tissue in a rat model of diabetes,
but also further explored more details of and the poten-
tial mechanisms involved in repair of DFU.
The key point in exploring the role of human stem
cells for the treatment of DFUs in the rat model is to
detect whether hADSCs participate in the restoration
process. In the previous report, superparamagnetic iron
oxide (SPIO) was employed to mark stem cells in
combination with an MRI technique [41]. However, this
method may not be suitable for long-term observation
because of the feeble MRI signal after the progressive
differentiation of stem cells in the target tissue. In our
study, the ZsGreen carried by the lentivirus was used to
mark the hADSCs and its labeling efficiency was
approximately 90 %. ZsGreen is one of the members of
the reef coral fluorescent protein (RCFP) family. The
novel fluorescent proteins were isolated from nonbiolu-
minescent species of reef-coral organisms. RCFPs do not
require external cofactors or substrates and can be used
in vivo or in vitro, with the same advantageous qualities
that make GFP a suitable reporter. RCFP variants with
brighter fluorescence and specific emission characteris-
tics have been generated and are now commercially
Fig. 6 Effect of hADSC treatment on key growth factors and inflammatory factors in the DFU tissues. a Levels of VEGF, bFGF, and TGF-β in the DFU
tissues at different time points were determined by enzyme-linked immunosorbent assay (ELISA).The level of VEGF, bFGF, and TGF-β was obviously
higher in the hADSC-treated group compared with the PBS-treated group on D7 but there were no significant differences on D3.The higher level of
VEGF and bFGF continued to D15 after treatment. b The R&D Systems Rat Cytokine Antibody Proteome Profiler Array system was used to screen for
the inflammation-related cytokines and chemokines in the DFU tissues on D3 after treatment. Quantification of cytokines and chemokines mean pixel
density was analyzed by Image-Pro Plus 6.0. *P < 0.05, **P < 0.01. d days, hADSC human adipose-derived stem cell, PBS phosphate-buffered saline
Shi et al. Stem Cell Research & Therapy  (2016) 7:155 Page 10 of 13
available [42]. Using this method, the fact that hADSCs
specifically localized to the ulcer area in a time-dependent
manner and significantly reduced the size of foot ulcers in
diabetic rats treated with hADSCs compared with control
rats was detected. Intravenously injected hADSCs can
migrate through veins to sites of injury in response to
potentially chemotactic signals to modulate inflammation
and contribute to tissue remodeling. Previous studies
found that implanted ADSCs were able to differentiate
into keratinocytes, fibroblasts, and epithelial cells in the
skin [38, 43, 44]. The ZsGreen-positive cells were
observed in the ulcer tissues 24 hours after the hADSC
transplantation, and the highest intensity was observed at
D7. The underlying mechanisms may be related with
progression of the wound healing process. The situation
of ZsGreen-hADSCs injected via the femoral vein into the
diabetic rat foot ulcers indicated that hADSCs were able
to migrate to the wound area and participate in the ulcer
healing process.
Both paracrine signaling and differentiation have been
implicated as the mechanisms for ADSCs to improve tissue
repair [45]. Factors secreted by ADSCs have been demon-
strated to exhibit a variety of biological activities including
facilitating skin wound closure [46] and suppressing immu-
noreaction [47]. As one of the most important findings of
this study, we detected higher levels of VEGF, bFGF, and
TGF-β in the foot ulcer tissues of rats in the hADSC-
treated group compared with the control group. It has been
widely recognized that VEGF is the most effective and
specific growth factor that regulates angiogenesis, while
bFGF is also an important growth factor in tissue regener-
ation because it affects migration and proliferation of fibro-
blasts, angiogenesis, as well as matrix deposition [48, 49].
Besides, TGF-β also possibly plays a pivotal role in healing
process by stimulating cellular proliferation, differentiation,
and ECM secretion and inhibiting inflammatory reaction
[50]. The paramount importance of blood supply in the
healing of wounds has long been appreciated. In the
present study, increased capillary density of the wound bed
in the hADSC-treated group was detected by immunohis-
tochemical analysis. Meanwhile, thicker granulation tissue
and complete re-epithelialization was achieved and the
formation of new blood vessels is necessary to sustain and
enhance newly formed granulation tissue. Granulation
tissue is essential to wound healing, because it is formed on
the surface of wounds to protect and provide nutrition to
wounds, consisting of fibroblasts, new capillaries, and
infiltrated inflammatory cells. Besides, a larger amount of
collagen deposition, promoted cellular proliferation, and
reduced apoptosis were found in the hADSC-treated group.
These data were consistent with the higher level of growth
factors we detected in the ulcer tissues. The application of
these growth factors could increase capillary formation,
collagen deposition, and the degree of granulation tissue.
The results revealed that growth factors secreted by ADSCs
played a particular and significant role in ADSC-mediated
accelerated wound healing, while topical application of
recombinant growth factors or cytokines directly to
stimulate diabetic wound healing has been demonstrated to
be without significant improvement because of the quick
diffusion and drying in the open wound. Infections are fre-
quent and disastrous complications in DM, and infections
of various types may be more common and are more often
severe in patients with DFUs [51]. Our data suggest that
transplanted hADSCs could modulate the synthesis of sev-
eral cytokines involved in the inflammatory process to in-
hibit the inflammatory reaction.
ADSCs are a particularly promising therapy for the
treatment of chronic nonhealing wounds. In the field of
wound healing, the possibilities of transplanted ADSCs
might have greater significance in diabetic wounds, where
there exists a complicated pathophysiology that we still do
not understand completely. Our study showed that trans-
planted hADSCs particularly migrated to or found home
in the wound tissues and created a biological microenvir-
onment to accelerate healing by a variety of mechanisms.
This comprehensive effect taken by ADSCs in chronic
nonhealing wounds is a remarkable advantage that any
previous single treatment could not achieve [21–24]. The
more accurate mechanisms should be revealed clearly to
develop more efficient treatment strategies. Long-term
systemic effects of stem cell therapy have yet to be estab-
lished, and the security of stem cell therapy should also be
of concern. The hypothesis that the immunomodulatory
effects of ADSCs may provide favorable conditions for
tumor growth could be hard to detect with the use of stem
cell in a short period of time [52]. Although no cases have
been reported from patients treated with ADSC
injections, long-term follow-up studies are necessary to
rule out any negative side effects.
Conclusions
In this study, transplanted hADSCs accelerated wound
healing in the DFU model of rats, in part by modulating
inflammation reaction and providing a source of growth
factors that promote angiogenesis, cellular proliferation,
and wound healing. Clinically, transplantation of ADSCs
may represent a new strategy for improvement of foot
ulcers in patients with diabetes.
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